These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 31613700)

  • 1. Targeting the Versatile Wnt/β-Catenin Pathway in Cancer Biology and Therapeutics: From Concept to Actionable Strategy.
    Dzobo K; Thomford NE; Senthebane DA
    OMICS; 2019 Nov; 23(11):517-538. PubMed ID: 31613700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the Wnt/β-catenin signaling pathway in cancer.
    Zhang Y; Wang X
    J Hematol Oncol; 2020 Dec; 13(1):165. PubMed ID: 33276800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in targeting the WNT/β-catenin signaling pathway in cancer.
    Chatterjee A; Paul S; Bisht B; Bhattacharya S; Sivasubramaniam S; Paul MK
    Drug Discov Today; 2022 Jan; 27(1):82-101. PubMed ID: 34252612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic potential of targeting the Wnt/β-catenin signaling pathway in colorectal cancer.
    Cheng X; Xu X; Chen D; Zhao F; Wang W
    Biomed Pharmacother; 2019 Feb; 110():473-481. PubMed ID: 30530050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small molecules from natural products targeting the Wnt/β-catenin pathway as a therapeutic strategy.
    Liu D; Chen L; Zhao H; Vaziri ND; Ma SC; Zhao YY
    Biomed Pharmacother; 2019 Sep; 117():108990. PubMed ID: 31226638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the Wnt/β-catenin signaling pathway in human cancers.
    Yao H; Ashihara E; Maekawa T
    Expert Opin Ther Targets; 2011 Jul; 15(7):873-87. PubMed ID: 21486121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of Wnt/β-catenin signaling pathway by bioactive food components.
    Tarapore RS; Siddiqui IA; Mukhtar H
    Carcinogenesis; 2012 Mar; 33(3):483-91. PubMed ID: 22198211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of small molecule inhibitors of the Wnt/β-catenin signaling pathway by targeting β-catenin/Tcf4 interactions.
    Yan M; Li G; An J
    Exp Biol Med (Maywood); 2017 Jun; 242(11):1185-1197. PubMed ID: 28474989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wnt/beta-catenin pathway: modulating anticancer immune response.
    Pai SG; Carneiro BA; Mota JM; Costa R; Leite CA; Barroso-Sousa R; Kaplan JB; Chae YK; Giles FJ
    J Hematol Oncol; 2017 May; 10(1):101. PubMed ID: 28476164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wnt/β-catenin signaling pathway in carcinogenesis and cancer therapy.
    Song P; Gao Z; Bao Y; Chen L; Huang Y; Liu Y; Dong Q; Wei X
    J Hematol Oncol; 2024 Jun; 17(1):46. PubMed ID: 38886806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the Canonical WNT/β-Catenin Pathway in Cancer Treatment Using Non-Steroidal Anti-Inflammatory Drugs.
    Vallée A; Lecarpentier Y; Vallée JN
    Cells; 2019 Jul; 8(7):. PubMed ID: 31311204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wnt signaling in cancer.
    Zhan T; Rindtorff N; Boutros M
    Oncogene; 2017 Mar; 36(11):1461-1473. PubMed ID: 27617575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Wnt-ow of opportunity: targeting the Wnt/beta-catenin pathway in breast cancer.
    Prosperi JR; Goss KH
    Curr Drug Targets; 2010 Sep; 11(9):1074-88. PubMed ID: 20545611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical role of Wnt/β-catenin signaling in driving epithelial ovarian cancer platinum resistance.
    Nagaraj AB; Joseph P; Kovalenko O; Singh S; Armstrong A; Redline R; Resnick K; Zanotti K; Waggoner S; DiFeo A
    Oncotarget; 2015 Sep; 6(27):23720-34. PubMed ID: 26125441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the Wnt/β-catenin signal pathway for the treatment of gastrointestinal cancer: Potential for advancement.
    Jin X; Wang S; Luo L; Yan F; He Q
    Biochem Pharmacol; 2024 Sep; 227():116463. PubMed ID: 39102994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wnt signaling and cancer development: therapeutic implication.
    Paul S; Dey A
    Neoplasma; 2008; 55(3):165-76. PubMed ID: 18348648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potential of targeting Wnt/β-catenin in colon cancer.
    Sebio A; Kahn M; Lenz HJ
    Expert Opin Ther Targets; 2014 Jun; 18(6):611-5. PubMed ID: 24702624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wnt/β-catenin signaling in cancers and targeted therapies.
    Yu F; Yu C; Li F; Zuo Y; Wang Y; Yao L; Wu C; Wang C; Ye L
    Signal Transduct Target Ther; 2021 Aug; 6(1):307. PubMed ID: 34456337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The anti-cancer activity of an andrographolide analogue functions through a GSK-3β-independent Wnt/β-catenin signaling pathway in colorectal cancer cells.
    Reabroi S; Saeeng R; Boonmuen N; Kasemsuk T; Saengsawang W; Suksen K; Zhu W; Piyachaturawat P; Chairoungdua A
    Sci Rep; 2018 May; 8(1):7924. PubMed ID: 29784906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of Small Molecules Targeting the Wnt Signaling Pathway in Cancer Stem Cells for the Treatment of Colorectal Cancer.
    Song L; Li Y; He B; Gong Y
    Clin Colorectal Cancer; 2015 Sep; 14(3):133-45. PubMed ID: 25799881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.